Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roslin Institute

Latest From Roslin Institute

Deals Shaping the Medical Industry (12/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Recent Dealmaking (02/2004)

Summarizing the month in European dealmaking.

Recent Dealmaking (05/2003)

Summarizing the month in European dealmaking.

Ardana Bioscience Ltd.

A recent spin-off from the UK's government-funded Medical Research Council, Ardana Bioscience Ltd. has been set up to commercialize research into women's health. On its agenda are new products for underserved areas such as menstrual disorders and endometriosis; more convenient contraceptive drugs--including the male pill--and a product to ease childbirth. Rather than commercializing a specific patented technology, like most spin-offs, the company has the option to acquire rights to any technology generated by the MRC's Human Reproductive Sciences Unit in Edinburgh over the next five years.
BioPharmaceutical Strategy
See All